Katherine Matthay

19PUBLICATIONS
68CO-AUTHORS
Cellular nervous systemPredictive and prognostic markersGene and molecular therapyInfant and child healthRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 28, 2026
Circulating Biomarkers of Disease Burden in Patients With Relapsed or Refractory Neuroblastoma Treated With 131I-MIBG Therapy: A Report From the New Approaches to Neuroblastoma Therapy Consortium.

|Jul 23, 2026
Factors Impacting Overall Survival Post-Relapse in High-Risk Neuroblastoma: Children's Oncology Group Outcomes From 2000 to 2019.

|May 12, 2026
Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I-Metaiodobenzylguanidine Radiotherapy in the Anti-GD2 Immunotherapy Era.

|Dec 23, 2025
Adaptive Clinical Neuroblastoma Risk Groups-Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project.

Wendy B London, Gabriela Villanueva, Derek Shyr

|Jun 23, 2025
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Thomas Cash, Araz Marachelian, Steven G DuBois

|Jun 01, 2024
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.

Erin K Barr, Arlene Naranjo, Clare J Twist

Pageof 4

Frequent Collaborators

9 joint publications

Steven G DuBois

5 joint publications

Julie R Park

4 joint publications

Barry Shulkin

4 joint publications

Susan L Cohn